Kwas zoledronowy stosowany przez dwa lata u Chinek z osteoporozą pomenopauzalną zwiększa gęstość mineralną tkanki kostnej i poprawia jakość życia związaną ze stanem zdrowia

Introduction: Osteoporosis is characterised by decreased bone mass and weakened bones, with an increased risk of fractures. Osteoporotic fracture, the most serious complication of osteoporosis, is related not only to lower bone mineral density (BMD), but also falls. Osteoporosis and fractures are associated with a decreased health-related quality of life (HRQL). Zoledronic acid (ZOL) is an intravenous once-yearly bisphosphonate that has been shown to be effective and safe in improving BMD and reducing fracture risk in controlled clinical trials.Material and methods: In this self-controlled, prospective trial, 220 postmenopausal women with osteoporosis (mean age 67 years) received a single infusion of ZOL 5 mg at baseline and month 12. BMD, HRQL and Fall Index (FI) were measured at baseline, and months 12 and 24 (before each use of ZOL). The main outcome measures were the changes in lumbar spine and hip BMD and the changes in HRQL, the Short Form-36 questionnaire (SF-36). Additional comparisons were based on the FI. LSD multiple comparisons were used in the comparisons of BMD, SF-36 domain scores and FI.Results: The patients had significantly higher L1-4, total hip, femoral neck and trochanter BMD (P < 0.05) with improved HRQL (P < 0.05) over two years of treatment of once-yearly ZOL 5mg. FI was reduced (P < 0.05) with oral daily elemental calcium and vitamin D in the treatment course.Conclusions: ZOL improves BMD and HRQL, especially in the physical aspects, over two years of treatment in women with postmenopausal osteoporosis, and can help improve balance ability. (Endokrynol Pol 2014; 65 (2): 96–104)Wstęp: Osteoporoza to schorzenie cechujące się obniżeniem masy kostnej i wytrzymałości mechanicznej kości z towarzyszącym zwiększeniem ryzyka złamań. Złamania osteoporotyczne, będące najpoważniejszym powikłaniem osteoporozy, wiążą się nie tylko z obniżoną gęstością mineralną tkanki kostnej (BMD, bone mineral density) ale też z upadkami. Z osteoporozą i złamaniami wiąże się obniżenie jakości życia związanej ze stanem zdrowia (HRQoL, health-related quality of life). Kwas zoledronowy (ZOL) to bisfosfonian w postaci dożylnej przeznaczony do podawania raz w roku, w przypadku którego w badaniach klinicznych z grupą kontrolną wykazano skuteczność i bezpieczeństwo w zwiększaniu BMD i zmniejszaniu ryzyka złamań.Materiał i metody: Autorzy przeprowadzili samodzielnie kontrolowane, prospektywne badanie z udziałem 220 znajdujących się w wieku pomenopauzalnym kobiet z osteoporozą (średnia wieku 67 lat), które otrzymały jednorazowo roztwór ZOL w dawce 5 mg na początku badania i 12 miesięcy później. Na początku badania, w 12. miesiącu i w 24. miesiącu badania (za każdym razem przed podaniem ZOL) oznaczano BMD, HRQoL i wskaźnik upadków (FI, fall index). Główne punkty końcowe obejmowały zmiany BMD w odcinku lędźwiowym kręgosłupa i BMD w okolicy biodra, a także zmiany HRQoL w kwestionariuszu SF-36. Dodatkowe porównania będą oparte na FI. W porównaniach wartości BMD, liczby punktów w poszczególnych domenach kwestionariusza SF-36 i wartości FI zastosowano metodę wielokrotnych porównań najmniejszej istotnej różnicy.Wyniki: U pacjentek stwierdzono znamiennie większe wartości BMD na poziomie L1–4, BMD w całkowitym obszarze biodra, BMD w obrębie szyjki kości udowej oraz BMD w obrębie krętarza (p < 0,05) oraz znamienną poprawę HRQoL (p < 0,05) w okresie 2 lat leczenia podawanym raz w roku ZOL w dawce 5 mg. Stwierdzono też zmniejszenie FI (p < 0,05) dzięki codziennemu przyjmowaniu wapnia i witaminy D w okresie leczenia.Wnioski: Stosowanie ZOL prowadzi do poprawy BMD i HRQoL, zwłaszcza w aspekcie fizycznym, w okresie 2 lat stosowania u kobiet z osteoporozą pomenopauzalną, i może przyczyniać się do poprawy zdolności utrzymania równowagi. (Endokrynol Pol 2014; 65 (2): 96–104

Adaptive Policy with Wait-kk Model for Simultaneous Translation

Simultaneous machine translation (SiMT) requires a robust read/write policy in conjunction with a high-quality translation model. Traditional methods rely on either a fixed wait-$k$ policy coupled with a standalone wait-$k$ translation model, or an adaptive policy jointly trained with the translation model. In this study, we propose a more flexible approach by decoupling the adaptive policy model from the translation model. Our motivation stems from the observation that a standalone multi-path wait-$k$ model performs competitively with adaptive policies utilized in state-of-the-art SiMT approaches. Specifically, we introduce DaP, a divergence-based adaptive policy, that makes read/write decisions for any translation model based on the potential divergence in translation distributions resulting from future information. DaP extends a frozen wait-$k$ model with lightweight parameters, and is both memory and computation efficient. Experimental results across various benchmarks demonstrate that our approach offers an improved trade-off between translation accuracy and latency, outperforming strong baselines.Comment: Accept to EMNLP 2023 main conference. 17 pages, 12 figures, 5 table

The calcium-permeable channel OSCA1.3 regulates plant stomatal immunity

Perception of biotic and abiotic stresses often leads to stomatal closure in plants 1,2. Rapid influx of calcium ions (Ca 2+) across the plasma membrane has an important role in this response, but the identity of the Ca 2+ channels involved has remained elusive 3,4. Here we report that the Arabidopsis thaliana Ca 2+-permeable channel OSCA1.3 controls stomatal closure during immune signalling. OSCA1.3 is rapidly phosphorylated upon perception of pathogen-associated molecular patterns (PAMPs). Biochemical and quantitative phosphoproteomics analyses reveal that the immune receptor-associated cytosolic kinase BIK1 interacts with and phosphorylates the N-terminal cytosolic loop of OSCA1.3 within minutes of treatment with the peptidic PAMP flg22, which is derived from bacterial flagellin. Genetic and electrophysiological data reveal that OSCA1.3 is permeable to Ca 2+, and that BIK1-mediated phosphorylation on its N terminus increases this channel activity. Notably, OSCA1.3 and its phosphorylation by BIK1 are critical for stomatal closure during immune signalling, and OSCA1.3 does not regulate stomatal closure upon perception of abscisic acid—a plant hormone associated with abiotic stresses. This study thus identifies a plant Ca 2+ channel and its activation mechanisms underlying stomatal closure during immune signalling, and suggests specificity in Ca 2+ influx mechanisms in response to different stresses

Peg Biology: Deciphering the Molecular Regulations Involved During Peanut Peg Development.

Peanut or groundnut is one of the most important legume crops with high protein and oil content. The high nutritional qualities of peanut and its multiple usage have made it an indispensable component of our daily life, in both confectionary and therapeutic food industries. Given the socio-economic significance of peanut, understanding its developmental biology is important in providing a molecular framework to support breeding activities. In peanut, the formation and directional growth of a specialized reproductive organ called a peg, or gynophore, is especially relevant in genetic improvement. Several studies have indicated that peanut yield can be improved by improving reproductive traits including peg development. Therefore, we aim to identify unifying principles for the genetic control, underpinning molecular and physiological basis of peg development for devising appropriate strategy for peg improvement. This review discusses the current understanding of the molecular aspects of peanut peg development citing several studies explaining the key mechanisms. Deciphering and integrating recent transcriptomic, proteomic, and miRNA-regulomic studies provide a new perspective for understanding the regulatory events of peg development that participate in pod formation and thus control yield

Steering Charge Kinetics of Tin Niobate Photocatalysts: Key Roles of Phase Structure and Electronic Structure

Abstract Tin niobate photocatalysts with the phase structures of froodite (SnNb2O6) and pyrochlore (Sn2Nb2O7) were obtained by a facile solvothermal method in order to explore the impact of phase structure and electronic structure on the charge kinetics and photocatalytic performance. By employing tin niobate as a model compound, the effects of phase structure over electronic structure, photocatalytic activity toward methyl orange solution and hydrogen evolution were systematically investigated. It is found that the variation of phase structure from SnNb2O6 to Sn2Nb2O7 accompanied with modulation of particle size and band edge potentials that has great consequences on photocatalytic performance. In combination with the electrochemical impedance spectroscopy (EIS), transient photocurrent responses, transient absorption spectroscopy (TAS), and the analysis of the charge-carrier dynamics suggested that variation of electronic structure has great impacts on the charge separation and transfer rate of tin niobate photocatalysts and the subsequent photocatalytic performance. Moreover, the results of the X-ray photoelectron spectroscopy (XPS) indicated that the existent of Sn4+ species in Sn2Nb2O7 could result in a decrease in photocatalytic activity. Photocatalytic test demonstrated that the SnNb2O6 (froodite) catalyst possesses a higher photocatalytic activity toward MO degradation and H2 evolution compared with the sample of Sn2Nb2O7 (pyrochlore). On the basis of spin resonance measurement and trapping experiment, it is expected that photogenerated holes, O2 −•, and OH• active species dominate the photodegradation of methyl orange

Identification of a novel PTH1R variant in a family with primary failure of eruption

Abstract Background Primary failure of tooth eruption (PFE) is a rare autosome genetic disorder that causes open bite. This work aimed to report a small family of PFE(OMIM: # 125,350) with a novel PTH1R variant. One of the patients has a rare clinical phenotype of the anterior tooth involved only. Case presentation The proband was a 13-year-old young man with an incomplete eruption of the right upper anterior teeth, resulting in a significant open-bite. His left first molar partially erupted. Family history revealed that the proband’s 12-year-old brother and father also had teeth eruption disorders. Genetic testing found a novel PTH1R variant (NM_000316.3 c.1325-1336del), which has never been reported before. The diagnosis of PFE was based on clinical and radiographic characteristics and the result of genetic testing. Bioinformatic analysis predicted this variant would result in the truncation of the G protein-coupled receptor encoded by the PTH1R, affecting its structure and function. Conclusion A novel PTH1R variant identified through whole-exome sequencing further expands the mutation spectrum of PFE. Patients in this family have different phenotypes, which reflects the characteristics of variable phenotypic expression of PFE

Ag Nanoparticles-Decorated PVDF Nanofiber/Net Membranes with Enhanced Filtration and Antibacterial Efficiency for Personal Protective Equipment

Medical protective masks with both high antibacterial activity and filtration efficiency have gained wide interest due to sporadic respiratory disease outbreaks. Previous studies have focused on improving a single function (antibacterial activity or filtration) of the mask performance. Herein, we developed silver nanoparticles-decorated PVDF membranes (AgNPs/PVDF) with both high antibacterial activity and filtration efficiency. Our results show that AgNPs/PVDF membranes have antibacterial efficiency of 99.98% and 99.86% against E. coliand S. aureus, respectively. The bacterial filtration efficiency is higher than 95%. PM0.26 filtration efficiency can be maintained above 95% after continuous filtration for 144 min. Adding AgNPs also promotes distinct hierarchical structure formation, which could improveme the filtration efficiency. This study provides a new methodology to fabricate antibacterial membranes doped with metal nanoparticles with promising applications in personal protective equipment development

The multifaceted role of placental growth factor in the pathogenesis and progression of bronchial asthma and pulmonary fibrosis: Therapeutic implications

Placental growth factor (PlGF) is a glycosylated dimeric protein that is homologous to vascular endothelial growth factor (VEGF). PlGF expression is upregulated in patients with bronchial asthma, suggesting that it plays a role in the pathogenesis of asthma. Bronchial asthma is characterized by chronic airway inflammation and airway hyperresponsiveness (AHR). After recurrent asthma attacks, pulmonary fibrosis develops and leads to airway remodeling and a further decline in lung function. In this review, we focused on the pivotal role of PlGF in chronic airway inflammation, AHR, and airway remodeling during bronchial asthma. Furthermore, we summarized data showing that PlGF may be a potential therapeutic target in bronchial asthma

Tunable Optical and Photocatalytic Performance Promoted by Nonstoichiometric Control and Site-Selective Codoping of Trivalent Ions in NaTaO₃

The present work explores a solid state route to synthesis of trivalent ions (Eu³⁺, La³⁺, etc.) doped NaTaO₃ with controlled nonstoichiometric chemistry and lattice parameters with an aim to exploring electronic structure and photocatalytic performance. All samples were fully characterized using X-ray diffraction (XRD), transmission electron microscopy (TEM), atomic absorption spectrophotometry, UV–vis diffuse reflectance spectroscopy, and photoluminescence measurement. By employing Eu³⁺ as a model trivalent ion doped in NaTaO₃ lattice, the effects of site-selective doping and nonstoichiometric chemistry on the lattice parameters, band gap structure, photocatalytic activity toward methylene blue solution, and photocatalytic hydrogen evolution were systematically investigated. A nonstoichiometric Na/Ta molar ratio led to site-selective occupation of Eu³⁺ ions which was changed from sole substitution to dual substitutions. Meanwhile, the nonstoichiometric Na/Ta molar ratio and site-selective occupation of Eu³⁺ resulted in a monotonous lattice expansion and local symmetry distortion. Lattice variation, doping effects, and its relevant defect chemistry had a great impact on the ν₃ mode vibration of the O–Ta bond, which became asymmetric and shifted toward higher wavenumbers. Moreover, contrary to theoretical predictions, Eu³⁺-doped NaTaO₃ nanocrystals showed an abnormal narrowing of the band gap energies and weak visible light absorption with variation of Na/Ta molar ratios, which is thought to be related to doping effects, defect chemistry, and variation of lattice parameters. With well-defined lattice structure and defect centers and electronic structure via nonstoichiometric control and trivalent ions doping, the photocatalytic activity of trivalent ions-doped NaTaO₃ can be well regulated and optimized

Rhodiola rosea L. Attenuates Cigarette Smoke and Lipopolysaccharide-Induced COPD in Rats via Inflammation Inhibition and Antioxidant and Antifibrosis Pathways

The root cause behind the development of chronic obstructive pulmonary disease (COPD) is cigarette smoke that induces the inflammation of the lung tissue and alveolar destruction. Long-term cigarette smoking can lead to deterioration in lung parenchymal function and cause structural changes in the lung, further resulting in pulmonary fibrosis. Rhodiola rosea L., a traditional medicinal perennial herb, is well known for its numerous pharmacological benefits, including anti-inflammation, antioxidant, antifatigue, antidepressive, and antifibrotic properties. Here, we evaluated the pharmacological effects and mechanisms of the Rhodiola rosea L. (RRL) macroporous resin extract on COPD caused by lipopolysaccharide (LPS) and cigarette smoke (CS) in rats. The RRL significantly improved the pathological structure of the lung tissue. Additionally, RRL decreased the infiltration of inflammatory cells and, subsequently, oxidative stress. Furthermore, the RNAseq assay indicated that RRL attenuated the CS and LPS-induced COPD via anti-inflammatory, antifibrotic, and antiapoptotic activities. Western blot analysis substantiated that the RRL resulted in upregulated levels of Nrf2 and HO-1 as well as downregulated levels of IκBα, NF-κB p65, α-SMA, and TGF-β1. Interestingly, the RRL could protect rats from CS and LPS-induced COPD by inhibiting the ERK1/2 and Smad3 signaling pathways and apoptosis. Thus, the RRL could attenuate CS and LPS-induced COPD through inflammation inhibition and antioxidant and antifibrosis pathways